{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "NCT04745299",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "InterventionArmGroupLabel",
                  "InterventionBrowseBranchAbbrev",
                  "InterventionBrowseBranchName",
                  "InterventionBrowseLeafAsFound",
                  "InterventionBrowseLeafId",
                  "InterventionBrowseLeafName",
                  "InterventionBrowseLeafRelevance",
                  "InterventionDescription",
                  "InterventionMeshId",
                  "InterventionMeshTerm",
                  "InterventionName",
                  "InterventionOtherName",
                  "InterventionType",
                  "IsFDARegulatedDevice",
                  "IsFDARegulatedDrug",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "InterventionArmGroupLabel": [
                              "Multiple administation group",
                              "Single cycle administration group",
                              "Control group",
                              "Multiple administation group",
                              "Single cycle administration group",
                              "Control group",
                              "Single cycle administration group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "AntiConv",
                              "NeuroAg",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anticonvulsants",
                              "Neuroprotective Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Immunologic"
                        ],
                        "InterventionBrowseLeafId": [
                              "M20833",
                              "M3398",
                              "M19924",
                              "M19657",
                              "M19926",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Riluzole",
                              "Anticonvulsants",
                              "Excitatory Amino Acid Antagonists",
                              "Neurotransmitter Agents",
                              "Neuroprotective Agents",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single cycle administration group : injections twice in a 26-day interval Multiple administration group : injections twice in a 26-day interval followed by repeated three times injections every three months",
                              "concomitant administration of Riluzole to all groups, except subjects to whom Riluzole administration is deemed impossible owing to adverse events as determined by medical experts",
                              "Single cycle administration group: Placebo comparator is injected three times every three months after injection of Lenzumestrocel twice in a 26-day interval.\n\nControl group: Placebo comparator is injected twice in a 26-day interval followed by repeated three times injcections every three months"
                        ],
                        "InterventionMeshId": [
                              "D000019782"
                        ],
                        "InterventionMeshTerm": [
                              "Riluzole"
                        ],
                        "InterventionName": [
                              "Lenzumestrocel",
                              "Riluzole",
                              "Placebo Comparator"
                        ],
                        "InterventionOtherName": [
                              "Neuronata-R inj",
                              "Autologous Bone Marrow derived Mesenchymal Stem Cell",
                              "Rilutek",
                              "Normal Saline Inj."
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04745299"
                        ]
                  }
            ]
      }
}